保险公司加力探索股权投资。 在分析人士看来，在低利率环境下，传统固收类资产收益率持续走低，股权投资成为险资提升投资收益 的重要抓手。股权投资基金存续期通常为10年至15年，与险资长期负债特性高度匹配。 与此同时，险资具有体量大、期限长、来源稳的特点，与股权投资基金"投早、投小、投长期、投科 技"的特征天然契合。基于此，险资通过资本纽带深度参与战略性新兴产业，推动新质生产力发展。 近日，中国人寿保险股份有限公司（下称"中国人寿"）披露公告称，拟投资设立一只养老产业基金和一 只长三角科创基金，认缴出资额合计近125亿元。 专注养老产业领域投资 根据公告，中国人寿（作为有限合伙人）拟与国寿启远（北京）养老产业投资管理有限公司（下称"国 寿启远"）（作为普通合伙人）于2026年9月30日前订立合伙协议，藉以成立北京国寿养老产业股权投资 基金二期（有限合伙）（其最终名称以工商登记信息为准）。 北京国寿养老产业股权投资基金二期存续期为15年，全体合伙人认缴出资总额为85亿元。其中，中国人 寿认缴出资额为84.915亿元，国寿启远认缴出资额为850万元。国寿股权投资有限公司将作为合伙企业 的管理人。 从投资方向来看，中国人 ...

在香港会议展览中心举办的第19届亚洲金融论坛上，上海市委常委、常务副市长吴伟在致辞中指出，时 值"十五五"开局之年，上海正着力构建"2+3+6+6"现代产业体系，具体表现为：推动传统产业数字化、 绿色化转型；加快发展集成电路、人工智能、生物医药三大先导产业；打造新一代电子信息、智能网联 新能源汽车、高端装备、先进材料、新能源及绿色低碳、时尚消费品六大新兴支柱产业；布局未来制 造、未来信息、未来材料、未来能源、未来空间、未来健康六个新的重点领域。 ...

Group 1: Core Technology Trends - The global technology wave is reshaping the economic landscape, with a shift from "what can be done" to "what should be done" in 2026, integrating social responsibility into technological development [2] - Artificial intelligence (AI) is the main driver of technological innovation, moving towards large-scale implementation and industrialization [2][3] - AI will transition from conceptual demonstrations to a phase of value realization, focusing on the integration of technology, industry, and governance [3] Group 2: Robotics and AI - Humanoid robots are entering a phase of large-scale trials, driven by breakthroughs in physical AI that allow robots to understand and interact with physical laws [4][5] - The development of humanoid robots will significantly change human-machine coexistence, requiring global collaboration and unified technical standards [5] Group 3: Commercial Space - The commercial space industry in China is poised for significant growth, transitioning from capability building to value creation, with a focus on reusable rockets and satellite networks [6][7] - 2026 is expected to be a pivotal year for the commercialization of space services, driven by advancements in satellite communication technology [7] Group 4: Future Transportation - Super high-speed rail, utilizing low vacuum tube technology, aims to achieve speeds over 1000 km/h, overcoming weather-related disruptions [8][9] - China is at the forefront of this technology, with significant engineering breakthroughs and ongoing trials [10] Group 5: Quantum Technology - Quantum technology is becoming a focal point for global research, with quantum error correction recognized as a key area for future advancements [11][12] - China is positioned in the leading tier of quantum communication and computing, with significant contributions expected from regions like Sichuan [12] Group 6: 6G Technology - The development of 6G technology is underway, promising speeds 10-100 times faster than 5G and enabling comprehensive coverage across air, land, and sea [13][14] - Sichuan is actively working on key technologies to accelerate the industrialization of 6G [15] Group 7: Controlled Nuclear Fusion - Research in controlled nuclear fusion is advancing towards engineering practice, with multiple countries exploring various technological routes [16][17] - China's strategic development in nuclear fusion is gaining momentum, supported by recent legislative frameworks [17] Group 8: Deep Space Exploration - Deep space exploration aims to expand human understanding of the universe, with significant global advancements in observational technology [18][19] - Sichuan is emerging as a key research hub for astronomy and deep space exploration, contributing to national strategic initiatives [19] Group 9: Brain-Computer Interfaces - Brain-computer interfaces are evolving to enhance human-machine interaction, with applications in healthcare and consumer technology [20][21] - Sichuan has developed a complete industry chain for brain-computer interfaces, with a market size of 1 billion yuan, entering a new phase of clinical application [22] Group 10: Biomedicine - The biomedicine sector is a critical area for innovation, integrating biotechnology with pharmaceuticals to drive high-quality development [23][24] - Sichuan is actively cultivating its biomedicine industry, focusing on various key and emerging sectors to enhance its competitive edge [24]

Core Viewpoint - Beijing is shifting its development strategy from quantity-focused growth to quality-driven development, emphasizing efficiency, quality, and sustainability in urban planning and economic growth [4]. Group 1: Achievements and Goals - During the "14th Five-Year Plan" period, Beijing reduced non-capital functions, decreasing urban construction land by approximately 50 square kilometers, while achieving an average GDP growth of 5.2% and surpassing economic milestones of 4 trillion and 5 trillion yuan [1]. - The "15th Five-Year Plan" outlines seven development goals and 13 specific tasks aimed at enhancing urban quality and promoting high-quality development [1][3]. Group 2: Industrial Transformation - Beijing has shifted from traditional scale expansion to a model driven by technology, knowledge, and high-value-added industries, successfully relocating over 594 general manufacturing enterprises and removing 1.2 million square meters of illegal constructions [2]. - The city has increased its industrial clusters from two to three in sectors such as information technology, artificial intelligence, and biomedicine, indicating a focus on high-tech industries [2]. Group 3: Urban Renewal and Infrastructure - Over the past five years, Beijing has implemented comprehensive renovations in over 2,600 old residential communities, added 41,000 public service spots, and increased the number of parks to 1,136, showcasing a commitment to urban renewal rather than expansion [2]. - The "15th Five-Year Plan" emphasizes urban renewal projects, including the renovation of over 300 old residential communities and the addition of 35,000 parking spaces, reflecting a focus on improving urban living conditions [3].

上海三大先导产业母基金再出手！ 1月26日，上海三大先导产业母基金发布第三批子基金遴选结果，共有17只子基金入选，其中集成电路4只、生物医药7只、人 工智能6只。 证券时报记者从上海三大先导产业母基金管理人上海国投先导公司获悉，第三批17只子基金总规模228.9亿元，上海三大先导 产业母基金拟投资47.1亿元，放大倍数4.86倍。 2025年7月28日，第三批子基金遴选公告正式发布，截至申报结束，共有53家机构申报。经过专家评审、立项尽调、现场答 辩、正式投决等流程，筛选出符合"上海方案"的优质子基金。 | 屋号 | 基金项目 | 中选机构 | 机构 | | --- | --- | --- | --- | | 1 | 上海生物医药产业股权投资基金二期合伙企业(有 | 上海上实资本管理有限公司 | 上实资本 | | | 限合伙) (拟) | | | | 2 | 德福上海创新股权投资基金合伙企业(有限合伙) | 广州德福投资咨询合伙企业 | 德福资本 | | | (拟) | (有限合伙) | | | 3 | 上海三生医药产业投资基金合伙企业(有限合伙) | 辽宁三生私募基金管理有限公 | 三生制药 | | | ( ...

Group 1 - The core viewpoint of the article is that Guangdong Province is expected to achieve over 19 trillion yuan in operating revenue from industrial enterprises by 2025, ranking first in the country [1] - Guangdong aims to have 76,000 industrial enterprises above designated size by 2025, with the industrial and information service sector contributing approximately 50% to GDP growth [1] - The province plans to optimize its industrial structure, with advanced manufacturing and high-tech manufacturing accounting for over 50% and 30% of the industrial enterprises, respectively [1] Group 2 - Guangdong is accelerating the digital transformation of its industrial sector, with over 8,400 enterprises undergoing digital upgrades and six enterprises recognized as national-level intelligent factories [2] - The province is focusing on new industrial tracks, including traditional, emerging, and future industries, to create significant contributions to economic and social development [2] - Guangdong will implement ongoing assessments for nascent industries and increase support for industries in growth and expansion phases to establish new investment hotspots [2]

| 序号 | 基金项目 | 中选机构 | 机构 品牌 | | --- | --- | --- | --- | | 1 | 上海澜起先导产业发展及并购基金(拟) | 上海木澜投资管理有限公司 | 木澜投资 | | 2 | 上海芯联启辰私募投资基金合伙企业(有限合伙) | 芯联私募基金管理(杭州) 들 伙企业(有限合伙) | 芯联资本 | | 3 | 上海自贸试验区四期股权投资基金合伙企业(有限 合伙)(拟) | 上海自贸区股权投资基金管理 有限公司 | 上海自贸区其 | | | | | 金 | | प | 上海石溪兆易智芯创业投资合伙企业(有限合伙) | 北京石溪清流私募基金管理有 | 石溪资本 | | | (拟) | 限公司 | | | 序号 | 星金项目 | 中选机构 | 机 廖 | | --- | --- | --- | --- | | 1 | 上海生物医药产业股权投资基金二期合伙企业 (有 限合伙)(拟) | 上海上实资本管理有限公司 | 上实资本 | | 2 | 德福上海创新股权投资基金合伙企业(有限合伙) | 广州德福投资咨询合伙企业 | 德福资本 | | | (拟) | (有限合伙) | | | ...

Core Insights - The Chinese government is focusing on the development of service trade, aiming to enhance the management of cross-border service trade and promote market openness [1][3] - Despite being the second-largest service trade country globally, China faces a significant service trade deficit, with a total service import and export value of 72,023.7 billion yuan in 2025, showing a year-on-year growth of 7.1% [2] Group 1: Service Trade Development Initiatives - The Ministry of Commerce plans to improve the negative list management system for cross-border service trade and gradually relax market access in service sectors [1][3] - There will be a focus on building national service trade innovation development demonstration zones and expanding the export of advantageous production services [1][3] - Encouragement will be given to professional service institutions in design, consulting, finance, accounting, and legal services to enhance their international service capabilities [1][3] Group 2: Regional Policies and Implementation - Recent policy documents from various provinces, including Shanghai and Guangdong, emphasize the promotion of service trade development [3] - Shanghai's "14th Five-Year Plan" highlights the need to strengthen service trade advantages and promote knowledge-intensive service trade [3] - Guangdong's implementation opinions propose 18 measures to develop digital trade and service trade, focusing on international market expansion and support systems [3][4] Group 3: Focus Areas for Service Trade - The government aims to promote high-quality imports in sectors such as healthcare and cultural entertainment, including hosting international film exhibitions and cultural exchange activities [4] - Support will be provided for the establishment of digital trade empowerment centers and comprehensive service platforms in regions like Guangzhou and Nansha [4]

今日午后开盘，疫苗概念快速拉升，疫苗、生物医药、创新药等细分领域表现亮眼，截至发稿，疫苗 ETF富国（159645）盘中涨3.87%，其成分股华兰疫苗涨20%，万孚生物涨超17%，智飞生物涨超13%。 消息面上，华兰疫苗发布公告，公司重组带状疱疹疫苗于近日获得国家药品监督管理局颁发的药物临床 试验批准通知书，获准开展临床试验。该进展被视为公司在重要预防领域管线布局的关键突破。市场预 期随着国内老龄化进程加快，带状疱疹疫苗接种需求增长空间较大。 疫苗ETF富国（159645）紧密跟踪国证疫苗与生物科技指数（980015）指数，指数由业务涉及生物科技 产业的50家A股上市公司组成，反映A股市场的生物科技产业中优质上市公司的整体表现，帮助投资者 精准捕捉医疗疫苗领域投资机会。 （文章来源：每日经济新闻） 相关机构表示，长期来看，疫苗渗透率提升叠加人口老龄化进程加快，如带状疱疹疫苗接种需求增长空 间较大。而国内创新型疫苗的加速审批上市、鼓励疫苗研发投入加大等相关政策的陆续发布，也将推动 我国疫苗行业快速发展。此外，疫苗出海也为疫苗行业拓宽了需求领域，近期海外如印度西孟加拉邦暴 发尼帕病毒疫情也引发关注。 ...

截至2026年1月26日 13:16，中证医药及医疗器械创新指数(931484)成分股方面涨跌互现，华兰生物领涨 5.00%，英科医疗上涨2.54%，华润三九上涨1.16%；南微医学领跌。医疗创新ETF(516820)下跌最新报 价0.37元。 生物医药概念午后快速拉升，消息面上，1月下旬，印度西孟加拉邦突发尼帕病毒疫情，已造成多名医 护人员感染，泰国、尼泊尔紧急升级防控。 数据显示，截至2025年12月31日，中证医药及医疗器械创新指数(931484)前十大权重股分别为药明康 德、恒瑞医药、迈瑞医疗、爱尔眼科、片仔癀、新和成、华东医药、康龙化成、艾力斯、甘李药业，前 十大权重股合计占比63.75%。 从资金净流入方面来看，医疗创新ETF近6天获得连续资金净流入，最高单日获得4053.70万元净流入， 合计"吸金"8499.86万元，日均净流入达1416.64万元。（数据来源：Wind） 风险提示：基金有风险，投资需谨慎。基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资 产，但不保证本基金一定盈利，也不保证最低收益。基金管理人提醒投资人基金投资的"买者自负"原 则，在做出投资决策后，基金运营状况与基金 ...